A Short Artificial Antimicrobial Peptide Shows Potential to Prevent or Treat Bone Infections

Overview

Journal Sci Rep

Specialty Science

Date 2017 May 6

PMID 28473710

Citations 19

Authors

N Bormann

A Koliszak

S Kasper

L Schoen

K Hilpert

R Volkmer

J Kikhney

B Wildemann

Affiliations

Soon will be listed here.

Abstract

Infection of bone is a severe complication due to the variety of bacteria causing it, their resistance against classical antibiotics, the formation of a biofilm and the difficulty to eradicate it. Antimicrobial peptides (AMPs) are naturally occurring peptides and promising candidates for treatment of joint infections. This study aimed to analyze the effect of short artificial peptides derived from an optimized library regarding (1) antimicrobial effect on different bacterial species, (2) efficacy on biofilms, and (3) effect on osteoblast‑like cells. Culturing the AMP-modifications with Escherichia coli, Enterococcus faecalis, Pseudomonas aeruginosa, Staphylococcus aureus (including clinical isolates of MRSA and MSSA) and Staphylococcus epidermidis identified one candidate that was most effective against all bacteria. This AMP was also able to reduce biofilm as demonstrated by FISH and microcalorimetry. Osteoblast viability and differentiation were not negatively affected by the AMP. A cation concentration comparable to that physiologically occurring in blood had almost no negative effect on AMP activity and even with 10% serum bacterial growth was inhibited. Bacteria internalized into osteoblasts were reduced by the AMP. Taken together the results demonstrate a high antimicrobial activity of the AMP even against bacteria incorporated in a biofilm or internalized into cells without harming human osteoblasts.

Citing Articles

Biofilm Producing Methicillin-Resistant (MRSA) Infections in Humans: Clinical Implications and Management.

Kaushik A, Kest H, Sood M, Steussy B, Thieman C, Gupta S Pathogens. 2024; 13(1).

PMID: 38251383 PMC: 10819455. DOI: 10.3390/pathogens13010076.

Effect of Camel Peptide on the Biofilm of and Formed on Orthopedic Implants.

Nowicka J, Janczura A, Pajaczkowska M, Chodaczek G, Szymczyk-Ziolkowska P, Walczuk U Antibiotics (Basel). 2023; 12(12).

PMID: 38136705 PMC: 10740474. DOI: 10.3390/antibiotics12121671.

Perspectives in Searching Antimicrobial Peptides (AMPs) Produced by the Microbiota.

Gallardo-Becerra L, Cervantes-Echeverria M, Cornejo-Granados F, Vazquez-Morado L, Ochoa-Leyva A Microb Ecol. 2023; 87(1):8.

PMID: 38036921 PMC: 10689560. DOI: 10.1007/s00248-023-02313-8.

Antimicrobial Proteins: Structure, Molecular Action, and Therapeutic Potential.

Hassan M, Flanagan T, Kharouf N, Bertsch C, Mancino D, Haikel Y Pharmaceutics. 2023; 15(1).

PMID: 36678702 PMC: 9864823. DOI: 10.3390/pharmaceutics15010072.

Vancomycin Resistance in and .

Li G, Walker M, De Oliveira D Microorganisms. 2023; 11(1).

PMID: 36677316 PMC: 9866002. DOI: 10.3390/microorganisms11010024.

References

Trebesius K, Leitritz L, Adler K, Schubert S, Autenrieth I, Heesemann J . Culture independent and rapid identification of bacterial pathogens in necrotising fasciitis and streptococcal toxic shock syndrome by fluorescence in situ hybridisation. Med Microbiol Immunol. 2000; 188(4):169-75. DOI: 10.1007/s004300000035. View

Steinstraesser L, Tack B, Waring A, Hong T, Boo L, Fan M . Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns. Antimicrob Agents Chemother. 2002; 46(6):1837-44. PMC: 127209. DOI: 10.1128/AAC.46.6.1837-1844.2002. View

Inzana J, Schwarz E, Kates S, Awad H . Biomaterials approaches to treating implant-associated osteomyelitis. Biomaterials. 2016; 81:58-71. PMC: 4745119. DOI: 10.1016/j.biomaterials.2015.12.012. View

Baldoni D, Steinhuber A, Zimmerli W, Trampuz A . In vitro activity of gallium maltolate against Staphylococci in logarithmic, stationary, and biofilm growth phases: comparison of conventional and calorimetric susceptibility testing methods. Antimicrob Agents Chemother. 2009; 54(1):157-63. PMC: 2798479. DOI: 10.1128/AAC.00700-09. View

Gristina A . Biomaterial-centered infection: microbial adhesion versus tissue integration. Science. 1987; 237(4822):1588-95. DOI: 10.1126/science.3629258. View

Hilpert K, Hancock R . Use of luminescent bacteria for rapid screening and characterization of short cationic antimicrobial peptides synthesized on cellulose using peptide array technology. Nat Protoc. 2007; 2(7):1652-60. DOI: 10.1038/nprot.2007.203. View

Fuchs T, Stange R, Schmidmaier G, Raschke M . The use of gentamicin-coated nails in the tibia: preliminary results of a prospective study. Arch Orthop Trauma Surg. 2011; 131(10):1419-25. PMC: 3175046. DOI: 10.1007/s00402-011-1321-6. View

Ageitos J, Sanchez-Perez A, Calo-Mata P, Villa T . Antimicrobial peptides (AMPs): Ancient compounds that represent novel weapons in the fight against bacteria. Biochem Pharmacol. 2016; 133:117-138. DOI: 10.1016/j.bcp.2016.09.018. View

Omardien S, Brul S, Zaat S . Antimicrobial Activity of Cationic Antimicrobial Peptides against Gram-Positives: Current Progress Made in Understanding the Mode of Action and the Response of Bacteria. Front Cell Dev Biol. 2016; 4:111. PMC: 5063857. DOI: 10.3389/fcell.2016.00111. View

10.

Hilpert K, Winkler D, Hancock R . Peptide arrays on cellulose support: SPOT synthesis, a time and cost efficient method for synthesis of large numbers of peptides in a parallel and addressable fashion. Nat Protoc. 2007; 2(6):1333-49. DOI: 10.1038/nprot.2007.160. View

11.

Ramon-Garcia S, Mikut R, Ng C, Ruden S, Volkmer R, Reischl M . Targeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides. Antimicrob Agents Chemother. 2013; 57(5):2295-303. PMC: 3632949. DOI: 10.1128/AAC.00175-13. View

12.

Bormann N, Schwabe P, Smith M, Wildemann B . Analysis of parameters influencing the release of antibiotics mixed with bone grafting material using a reliable mixing procedure. Bone. 2013; 59:162-72. DOI: 10.1016/j.bone.2013.11.005. View

13.

Cherkasov A, Hilpert K, Jenssen H, Fjell C, Waldbrook M, Mullaly S . Use of artificial intelligence in the design of small peptide antibiotics effective against a broad spectrum of highly antibiotic-resistant superbugs. ACS Chem Biol. 2008; 4(1):65-74. DOI: 10.1021/cb800240j. View

14.

Diefenbeck M, Schrader C, Gras F, Muckley T, Schmidt J, Zankovych S . Gentamicin coating of plasma chemical oxidized titanium alloy prevents implant-related osteomyelitis in rats. Biomaterials. 2016; 101:156-64. DOI: 10.1016/j.biomaterials.2016.05.039. View

15.

Alt V, Bitschnau A, Osterling J, Sewing A, Meyer C, Kraus R . The effects of combined gentamicin-hydroxyapatite coating for cementless joint prostheses on the reduction of infection rates in a rabbit infection prophylaxis model. Biomaterials. 2006; 27(26):4627-34. DOI: 10.1016/j.biomaterials.2006.04.035. View

16.

Wiegand I, Hilpert K, Hancock R . Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc. 2008; 3(2):163-75. DOI: 10.1038/nprot.2007.521. View

17.

Josse J, Velard F, Gangloff S . Staphylococcus aureus vs. Osteoblast: Relationship and Consequences in Osteomyelitis. Front Cell Infect Microbiol. 2015; 5:85. PMC: 4660271. DOI: 10.3389/fcimb.2015.00085. View

18.

Fass R, Barnishan J . Effect of divalent cation concentrations on the antibiotic susceptibilities of nonfermenters other than Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1979; 16(4):434-8. PMC: 352878. DOI: 10.1128/AAC.16.4.434. View

19.

Strobel C, Bormann N, Kadow-Romacker A, Schmidmaier G, Wildemann B . Sequential release kinetics of two (gentamicin and BMP-2) or three (gentamicin, IGF-I and BMP-2) substances from a one-component polymeric coating on implants. J Control Release. 2011; 156(1):37-45. DOI: 10.1016/j.jconrel.2011.07.006. View

20.

Trampuz A, Zimmerli W . Diagnosis and treatment of infections associated with fracture-fixation devices. Injury. 2006; 37 Suppl 2:S59-66. DOI: 10.1016/j.injury.2006.04.010. View